X-Site Medical LLC

Wall Street analysts have been dubious about commercial prospects for Johnson & Johnson ’s Olysio (simeprevir) as it will be the third protease inhibitor to market for hepatitis C, but early mark

The price gap between branded and generic pharmaceuticals is at its widest point since 2008 when Express Scripts Holding Co. began calculating indexes for each, according to data released by pharm